James R. Kasinger
General Counsel at CRISPR Therapeutics AG (CRSP)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $1.4M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Oct 8SEC | CRSPCRISPR Therapeutics AG | Sell Plan | 1,99094,784 held (−2%) | $60.04 | $119K | -11.1% |
| Sep 24SEC | CRSPCRISPR Therapeutics AG | Sell Plan | 10,40094,784 held (−10%) | $60.24 | $626K | -11.4% |
| Mar 24SEC | CRSPCRISPR Therapeutics AG | Sell | 3,18294,308 held (−3%) | $46.78 | $149K | +14.1% |
| Mar 17SEC | CRSPCRISPR Therapeutics AG | Sell | 3,45091,240 held (−4%) | $48.26 | $166K | +10.6% |
| Mar 12SEC | CRSPCRISPR Therapeutics AG | Sell | 2,80087,815 held (−3%) | $52.80 | $148K | +1.1% |
| Feb 20SEC | CRSPCRISPR Therapeutics AG | Sell | 2,11285,115 held (−2%) | $52.58 | $111K | +1.5% |
| Oct 15SEC | CRSPCRISPR Therapeutics AG | Sell | 1,07683,402 held (−1%) | $66.60 | $72K | -19.8% |
- Sell
General Counsel James R. Kasinger sold $119K of CRSP at $60.04 — pre-scheduled 10b5-1 plan sale.
- Sell
General Counsel James R. Kasinger sold $626K of CRSP at $60.24 — pre-scheduled 10b5-1 plan sale.